Prenatal Ultrasound Screening of Intestinal Malrotation With a Higher Risk of Volvulus

NCT03356314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2018-04-24

No results posted yet for this study

Summary

The aim of this study was to assess the value of an unusual relative position of the superior mesenteric artery (SMA) and vein (SMV) to screen intestinal malrotation with a higher risk of volvulus.

First, feasibility study was done to prove the reproducibility of ultrasound in diagnosis of anormal mesenteric vessels position.

A systematic screening of the mesenteric vessels position was performed at each pregnancy required ultrasound.

When the fœtus had an unusual position of the mesenteric vessels, an MRI was suggested between 30 and 35 GA and the couple met the pediatric surgery team.

Few days after birth, an abdominal ultrasound was achieved as well as a barium enema and upper gastrointestinal. If there were a hight probability of malrotation with a higher risk of volvulus, a prophylactic surgery was proposed. The children were flollowed up during 1 year.

Conditions

  • Intestinal Malrotation

Interventions

OTHER

MRI between 30-35 GA

MRI between 30-35 GA

OTHER

Pediatric surgeon meeting

Pediatric surgeon meeting

OTHER

Postnatal abdominal ultrasound, barium enema and upper gastrointestinal

Postnatal abdominal ultrasound, barium enema and upper gastrointestinal

OTHER

+/- prophylactic surgery

+/- prophylactic surgery

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • florent FUCHS · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-05-01
Completion
2017-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356314 on ClinicalTrials.gov